{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05737706",
            "orgStudyIdInfo": {
                "id": "CA246-0005"
            },
            "secondaryIdInfos": [
                {
                    "id": "CA246-0005",
                    "type": "OTHER",
                    "domain": "Bristol-Myers Squibb Protocol ID"
                },
                {
                    "id": "1133-001",
                    "type": "OTHER",
                    "domain": "Mirati Therapeutics Protocol ID"
                }
            ],
            "organization": {
                "fullName": "Mirati Therapeutics Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation",
            "officialTitle": "A Phase 1/2 Multiple Expansion Cohort Trial of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "study-of-in-patients-with-advanced-solid-tumors-harboring-a-kras-mutation"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-08-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-08-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-02-10",
            "studyFirstSubmitQcDate": "2023-02-10",
            "studyFirstPostDateStruct": {
                "date": "2023-02-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-18",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Mirati Therapeutics Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A Phase 1/2 study of MRTX1133 in solid tumors harboring a KRAS G12D mutation.",
            "detailedDescription": "This first-in-human clinical trial will begin with an exploration of MRTX1133 dose and regimen. As potentially viable regimens are identified, Phase 1b expansion cohorts may be implemented to ensure collection of sufficient safety and PK information, and early evidence of clinical activity are available to recommend Phase 2 regimens. In Phase 2, separate cohorts of patients by histological diagnosis and/or baseline characteristics will be evaluated for the clinical activity and efficacy of MRTX1133."
        },
        "conditionsModule": {
            "conditions": [
                "Solid Tumor",
                "Advanced Solid Tumor",
                "Non-small Cell Lung Cancer",
                "Colo-rectal Cancer",
                "Pancreatic Adenocarcinoma"
            ],
            "keywords": [
                "Non-Small Cell Lung Cancer",
                "NSCLC",
                "colorectal cancer",
                "CRC",
                "PDAC",
                "KRAS",
                "G12D",
                "Solid Tumor",
                "Advanced Solid Tumor",
                "Malignant",
                "Pancreatic Cancer",
                "Pancreatic Adenocarcinoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 386,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phase 1/1B",
                    "type": "EXPERIMENTAL",
                    "description": "Dose Escalation/Evaluation",
                    "interventionNames": [
                        "Drug: MRTX1133"
                    ]
                },
                {
                    "label": "Phase 2",
                    "type": "EXPERIMENTAL",
                    "description": "MRTX1133 recommended Phase 2 dose administered to separate cohorts of patients with selected solid tumor malignancies with KRAS G12D mutation to include the following: NSCLC, PDAC, CRC, Other Solid Tumors",
                    "interventionNames": [
                        "Drug: MRTX1133"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "MRTX1133",
                    "description": "KRAS G12D Inhibitor",
                    "armGroupLabels": [
                        "Phase 1/1B",
                        "Phase 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Phase 1: Number of Patients who Experience Dose-Limiting Toxicity",
                    "timeFrame": "21 Days"
                },
                {
                    "measure": "Phase 1/1b: Number of patients who experience a treatment-related adverse event",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Phase 2: Objective response rate (ORR)",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Phase 2: Duration of response (DOR)",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Phase 2: Progression free survival (PFS)",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Phase 2: Overall survival (OS)",
                    "timeFrame": "2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Area under plasma concentration versus time curve (AUC)",
                    "timeFrame": "up to 4 days"
                },
                {
                    "measure": "Time to achieve maximal plasma concentration (Tmax)",
                    "timeFrame": "up to 4 days"
                },
                {
                    "measure": "Maximum observed plasma concentration (Cmax)",
                    "timeFrame": "up to 4 days"
                },
                {
                    "measure": "Terminal elimination half-life (t1/2)",
                    "timeFrame": "up to 4 days"
                },
                {
                    "measure": "Apparent total plasma clearance when dosed orally (CL/F)",
                    "timeFrame": "up to 4 days"
                },
                {
                    "measure": "Apparent volume of distribution when dosed orally (Vz/F)",
                    "timeFrame": "up to 4 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed diagnosis of a solid tumor malignancy harboring KRAS G12D mutation in tumor tissue or ctDNA.\n* Unresectable or metastatic disease.\n* Patients must have received standard therapies appropriate for their tumor type and stage; first-line treatment for PDAC for certain cohorts.\n* Presence of tumor lesions to be evaluated per RECIST v1.1:\n\n  1. in the Phase 1 dose escalation cohorts, patients must have measurable or evaluable disease.\n  2. in the Phase 1b and Phase 2 cohorts, patients must have measurable disease.\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.\n* Adequate organ function.\n* Age \u2265 18 years\n\nExclusion Criteria:\n\n* Active brain metastases or carcinomatous meningitis.\n* Prior treatment with a KRAS G12D inhibitor (Phase 1b \\& Phase 2 only).\n* History of significant hemoptysis or hemorrhage within 4 weeks of the first dose of study treatment.\n* History of intestinal disease, inflammatory bowel disease, major gastric surgery, or other gastrointestinal conditions likely to alter absorption of study treatment or result in inability to swallow oral medications.\n* History of malignant small bowel obstruction.\n* Cardiac abnormalities.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "BMS Clinical Trials Contact Center www.BMSClinicalTrials.com",
                    "role": "CONTACT",
                    "phone": "855-907-3286",
                    "email": "Clinical.Trials@bms.com"
                },
                {
                    "name": "First line of the email MUST contain the NCT# and Site #.",
                    "role": "CONTACT"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Bristol-Myers Squibb",
                    "affiliation": "Bristol-Myers Squibb",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic Hospital",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85054",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tanios Bekaii-Saab, Site 311",
                            "role": "CONTACT",
                            "phone": "480-301-8000"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "Yale Cancer Center",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06520 8028",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Patricia LoRusso, Site 309",
                            "role": "CONTACT",
                            "phone": "313-745-6258"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Florida Cancer Specialists & Research Institute (FCS) - Villages East",
                    "status": "RECRUITING",
                    "city": "Lady Lake",
                    "state": "Florida",
                    "zip": "32159 8987",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cesar Perez Batista, Site 301",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.91749,
                        "lon": -81.92286
                    }
                },
                {
                    "facility": "John Hopkins Medicine - Hematology/oncology",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21231",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nilofer Azad, Site 306",
                            "role": "CONTACT",
                            "phone": "410-502-2995"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Massachusetts General Hospital (MGH)",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114 3117",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Colin Weekes, Site 308",
                            "role": "CONTACT",
                            "phone": "720-848-0030"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Dana Farber Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Haeseong Park, Site 310",
                            "role": "CONTACT",
                            "phone": "86640833243147471171"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "South Texas Accelerated Research Therapeutics (START) - Midwest",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49546",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sreenivasa Chandana, Site 314",
                            "role": "CONTACT",
                            "phone": "269-993-6056"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "Memorial Sloan-Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065 6800",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yonina Murciano-Goroff, Site 312",
                            "role": "CONTACT",
                            "phone": "646-888-4226"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "SCRI Oncology Partners",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Melissa Johnson, Site 303",
                            "role": "CONTACT",
                            "phone": "615-329-7274"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "UT MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "David Hong, Site 302",
                            "role": "CONTACT",
                            "phone": "713-563-1930"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "The START Center for Cancer Care",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229 3307",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kyriakos Papadopoulos, Site 304",
                            "role": "CONTACT",
                            "phone": "210-593-5258"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Next Oncology - Oncology",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Anthony Tolcher, Site 313",
                            "role": "CONTACT",
                            "phone": "210-300-9044"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Fairfax Northern Virginia Hematology Oncology PC",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alexander Spira, Site 305",
                            "role": "CONTACT",
                            "phone": "703-280-5390"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "University of Washington (UW) - Seattle Cancer Care Alliance",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109 1023",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elena Gabriela Chiorean, Site 307",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "BMS Clinical Trial Information",
                    "url": "https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html"
                },
                {
                    "label": "FDA Safety Alerts and Recalls",
                    "url": "http://www.fda.gov/MEDWATCH/safety.htm"
                },
                {
                    "label": "BMS Clinical Trial Patient Recruiting",
                    "url": "https://www.BMSStudyConnect.com"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000002289",
                    "term": "Carcinoma, Non-Small-Cell Lung"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000002283",
                    "term": "Carcinoma, Bronchogenic"
                },
                {
                    "id": "D000001984",
                    "term": "Bronchial Neoplasms"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "asFound": "Non-small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13110",
                    "name": "Pancreatic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5540",
                    "name": "Carcinoma, Bronchogenic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5260",
                    "name": "Bronchial Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "T4387",
                    "name": "Pancreatic Cancer",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}